• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

In Latin America, Heat Warnings Can Prevent Deaths
Residents of Mexico City take shelter from the heat in a covered area, on a central street in the capital, in the month of March, when spring has not even arrived yet in the country. Heat waves will become more frequent and will last longer, due to the climate emergency. CREDIT: Emilio Godoy/IPSBy Emilio GodoyMEXICO CITY, Mar 14 2023 (IPS) On Mar. 9, more than half of Mexico reported maximum temperatures above 30 degrees Celsius, although spring has not even arrived yet in this Latin American country located in the northern hemisphere. In fact, the Megalopolis Environmental Commission, which brings together the federal gov...
Source: IPS Inter Press Service - Health - March 14, 2023 Category: International Medicine & Public Health Authors: Emilio Godoy Tags: Climate Change Development & Aid Editors' Choice Environment Headlines Health Latin America & the Caribbean Regional Categories Extreme Weather heat waves Mexico Source Type: news

Cost-Effectiveness of Bariatric Surgery Compared With Nonsurgical Treatment in People With Obesity and Comorbidity in Colombia
ConclusionThe current study provides evidence that bariatric surgery is a cost-effective alternative among some cohorts in the Colombian setting. For obese patients with sleep apnea or diabetes, bariatric surgery is a recommendable alternative (dominant and cost-effective, respectively) for the Colombian healthcare system.
Source: Value in Health Regional Issues - May 11, 2019 Category: International Medicine & Public Health Source Type: research

Cost-Efectiveness Of Dabigatran In Non Valvular Atrial Fibrillation In Colombia
Atrial fibrillation (AF) is the most common cardiac rhythm disorder; it increases stroke risk 5 to 6 times. Prevalence in Colombia has been estimated in 3.6% in population age 60 or over (some 180 000 potential patients). The aim of this study was to estimate cost-effectiveness of dabigatran 110 mg and 150 mg BID as a therapy for non valvular AF in Colombian population.
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: J.J. Triana, C. Castañeda-Cardona, L. Parada, D. Rosselli Source Type: research